Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 28-02-2023

Claim your CME credit at https://reachmd.com/programs/cme/clarifying-the-value-of-anti-egfr-therapy-in-metastatic-colorectal-cancer/13269/

Even with the recent advances in therapeutic options for patients with BRAF V600E-mutated metastatic colorectal cancer (mCRC), they still have an uphill climb ahead of them.

How will the new standard of care in the second-line setting address global challenges and unmet needs regarding molecular profiling and treatment sequencing options?

Join us as 3 experts, Dr. Scott Kopetz, Dr. Elizabeth Smyth, and Dr. Elena Elez, untangle these new advances in treatment and offer their insights on how diagnostic testing can improve patient outcomes.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD